-+ 0.00%
-+ 0.00%
-+ 0.00%

Fulcrum Therapeutics grants 55,500 inducement stock options at $7.02 per share

PUBT·05/08/2026 20:31:36
Listen to the news
Fulcrum Therapeutics grants 55,500 inducement stock options at $7.02 per share
  • Fulcrum Therapeutics granted 55,500 non-statutory stock options to two new employees under its 2022 Inducement Stock Incentive Plan, as amended.
  • Options carry exercise price of $7.02 per share, based on May 4, 2026 closing price; 10-year term.
  • Vesting runs over four years, with 25% vesting on first anniversary of start date; remainder vests quarterly at 6.25% over next 12 quarters, subject to continued service.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fulcrum Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605081630PRIMZONEFULLFEED9714131) on May 08, 2026, and is solely responsible for the information contained therein.